<DOC>
	<DOCNO>NCT00276978</DOCNO>
	<brief_summary>20 therapy-refractory patient major depression treat 3 week Aripiprazole 10 mg/d . Effectivity assess use pre-post comparison different psychopathological rating scale patient adherence .</brief_summary>
	<brief_title>Aripiprazole Augmentation Therapy Treatment-resistant Depression</brief_title>
	<detailed_description>This open pilot study use pre-post comparison . 20 treatment-refractory patient major depression diagnose DSM-IV include . Psychotic feature depression exclude score 2 less PANSS subscales P1 , P3 P6 . Treatment resistance define history non-response two antidepressant different class acceptable dose period confirm retrospectively . If possible , treatment compliance confirm plasma level examination . After informed consent , visit 1 perform day 0 ( inclusion criterion , history , demographic , physical examination , vital sign , HAMD , MADRS , CGI , BDI , lab ) . Study medication start day 1 , antidepressive therapy continue stable dose end study . Patients receive adjunctive augmentation therapy 10 mg/d aripiprazole . Study visit perform day 3 , 7 , 14 21 ( visit 2-5 : vital sign , HAMD , MADRS , CGI , BDI , lab ) . In addition HAM-D MADRS score , patient perform self-rating ( BDI ) . Aripiprazole plasma level measure end treatment period ass compliance detect putative correlation drug plasma level efficacy .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>major depression without psychotic feature ( DSMIV definition ) therapy resistance ( two course antidepressant different class 3 week adequate dose ) HAMD score greater/equal 17 age 1870 bipolar disorder active alcohol illicit drug use female without effective contraception severe medical condition psychotic feature</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Therapy-resistant Depression</keyword>
	<keyword>add-on therapy depression</keyword>
</DOC>